Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: Role of Lpp in modulating host immune response, NF-κB activation and cell death

Microbial Pathogenesis

Volumn 48, Issue 1, 2010, Pages 42-52

  Liu, Tie ^a   Agar, Stacy L ^a   Sha, Jian ^a   Chopra, Ashok K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Apoptosis; Braun lipoprotein; Host immune response; Mouse model of infection; NF B; Yersinia pestis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; BRAUN LIPOPROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOPROTEIN; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; GENE ACTIVATION; GENE DELETION; HOST CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IN VITRO STUDY; INFECTION RESISTANCE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLAGUE; PRIORITY JOURNAL; SEPTIC SHOCK; SPLEEN CELL; T LYMPHOCYTE; TYPE III SECRETION SYSTEM; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; APOPTOSIS; BACTERIAL OUTER MEMBRANE PROTEINS; FEMALE; GENE DELETION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; MACROPHAGES; MICE; NF-KAPPA B P50 SUBUNIT; SPLEEN; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS; YERSINIA PESTIS;

ANIMALIA; MURINAE; MUS; YERSINIA PESTIS;

EID: 72149091437     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.09.002     Document Type: Article

References (68)

1. Perry R.D., and Fetherston J.D. Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev 10 (1997) 35-66
2. Inglesby T.V., Dennis D.T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283 (2000) 2281-2290
3. Hill J., Copse C., Leary S., Stagg A.J., Williamson E.D., and Titball R.W. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect Immun 71 (2003) 2234-2238
4. Sebbane F., Jarrett C.O., Gardner D., Long D., and Hinnebusch B.J. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci 103 (2006) 5526-5530
5. World Health Organization. Health aspects of chemical and biological weapons. 1st ed. (1970), World Health Organization Department of Communicable Diseases, Geneva, Switzerland 98-109
6. Straley S.C., and Perry R.D. Environmental modulation of gene expression and pathogenesis in Yersinia. Trends Microbiol 3 (1995) 310-317
7. Marketon M.M., DePaolo R.W., DeBord K.L., Jabri B., and Schneewind O. Plague bacteria target immune cells during infection. Science 309 (2005) 1739-1741
8. Cornelis G.R., and Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 23 (1997) 861-867
9. Straley S.C., Skrzypek E., Plano G.V., and Bliska J.B. Yops of Yersinia spp. pathogenic for humans. Infect Immun 61 (1993) 3105-3110
10. Hantke K., and Braun V. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur J Biochem 34 (1973) 284-296
11. Madan Babu M., and Sankaran K. DOLOP - database of bacterial lipoproteins. Bioinformatics 18 (2002) 641-643
12. Beermann C., Lochnit G., Geyer R., Groscurth P., and Filgueira L. The lipid component of lipoproteins from Borrelia burgdorferi: structural analysis, antigenicity, and presentation via human dendritic cells. Biochem Biophys Res Commun 267 (2000) 897-905
13. Brandt M.E., Riley B.S., Radolf J.D., and Norgard M.V. Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun 58 (1990) 983-991
14. Pal U., de Silva A.M., Montgomery R.R., Fish D., Anguita J., Anderson J.F., et al. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest 106 (2000) 561-569
15. Hayashi S., and Wu H.C. Lipoproteins in bacteria. J Bioenerg Biomembr 22 (1990) 451-471
16. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285 (1999) 736-739
17. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
18. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 (2004) 2195-2224
19. Karin M., and Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12 (2000) 85-98
20. Sweet C.R., Conlon J., Golenbock D.T., Goguen J., and Silverman N. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 9 (2007) 2700-2715
21. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2 (2002) 301-310
22. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 3 (2002) 221-227
23. Byrne G.I., and Ojcius D.M. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2 (2004) 802-808
24. DeFilippis R.A., Goodwin E.C., Wu L., and DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 77 (2003) 1551-1563
25. Navarre W.W., and Zychlinsky A. Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies. Cell Microbiol 2 (2000) 265-273
26. Ruckdeschel K., Roggenkamp A., Lafont V., Mangeat P., Heesemann J., and Rouot B. Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun 65 (1997) 4813-4821
27. Monack D.M., Mecsas J., Ghori N., and Falkow S. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A 94 (1997) 10385-10390
28. Mills S.D., Boland A., Sory M.P., van der Smissen P., Kerbourch C., Finlay B.B., et al. Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci U S A 94 (1997) 12638-12643
29. Lemaitre N., Sebbane F., Long D., and Hinnebusch B.J. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun 74 (2006) 5126-5131
30. Sha J., Agar S.L., Baze W.B., Olano J.P., Fadl A.A., Erova T.E., et al. Braun lipoprotein (Lpp) contributes to the virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect Immun 76 (2008) 1390-1409
31. Agar S.L., Sha J., Foltz S.M., Erova T.E., Walberg K.G., Parham T.E., et al. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 154 (2008) 1939-1948
32. + T cells. J Immunol 156 (1996) 1458-1468
33. Autenrieth I.B., and Heesemann J. In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol 181 (1992) 333-338
34. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
35. Zhang Y., Ting A.T., Marcu K.B., and Bliska J.B. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J Immunol 174 (2005) 7939-7949
36. Titball R.W., and Williamson E.D. Yersinia pestis (plague) vaccines. Expert Opin Biol Ther 4 (2004) 965-973
37. Girard G. Plague. Annu Rev Microbiol 9 (1955) 253-276
38. Williamson E.D., Stagg A.J., Eley S.M., Taylor R., Green M., Jones S.M., et al. Kinetics of the immune response to the (F1 + V) vaccine in models of bubonic and pneumonic plague. Vaccine 25 (2007) 1142-1148
39. DeBord K.L., Anderson D.M., Marketon M.M., Overheim K.A., DePaolo R.W., Ciletti N.A., et al. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 74 (2006) 4910-4914
40. Yang X., Hinnebusch B.J., Trunkle T., Bosio C.M., Suo Z., Tighe M., et al. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 178 (2007) 1059-1067
41. Jarrett C.O., Sebbane F., Adamovicz J.J., Andrews G.P., and Hinnebusch B.J. Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague. Infect Immun 72 (2004) 2052-2056
42. Philipovskiy A.V., and Smiley S.T. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun 75 (2007) 878-885
43. Feodorova V.A., Pan'kina L.N., Savostina E.P., Sayapina L.V., Motin V.L., Dentovskaya S.V., et al. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 25 (2007) 7620-7628
44. Anisimov A.P., Shaikhutdinova R.Z., Pan'kina L.N., Feodorova V.A., Savostina E.P., Bystrova O.V., et al. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice. J Med Microbiol 56 (2007) 443-453
45. Zhang H., Peterson J.W., Niesel D.W., and Klimpel G.R. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J Immunol 159 (1997) 4868-4878
46. Entleutner M., Traeger T., Westerholt A., Holzmann B., Stier A., Pfeffer K., et al. Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis. Int J Colorectal Dis 21 (2006) 64-70
47. Yamanaka H., Hoyt T., Bowen R., Yang X., Crist K., Golden S., et al. An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague. Vaccine 27 (2009) 80-87
48. Agar S.L., Sha J., Baze W.B., Erova T.E., Foltz S.M., Suarez G., et al. Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague. Microbiology 155 (2009) 3247-3259
49. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62 (1998) 379-433
50. Monack D.M., Mecsas J., Bouley D., and Falkow S. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188 (1998) 2127-2137
51. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., et al. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285 (1999) 1920-1923
52. Zhang Y., and Bliska J.B. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect Immun 71 (2003) 1513-1519
53. Haase R., Kirschning C.J., Sing A., Schrottner P., Fukase K., Kusumoto S., et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol 171 (2003) 4294-4303
54. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312 (2006) 1211-1214
55. Park H., Teja K., O'Shea J.J., and Siegel R.M. The Yersinia effector protein YpkA induces apoptosis independently of actin depolymerization. J Immunol 178 (2007) 6426-6434
56. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
57. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., and Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 95 (1998) 588-593
58. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
59. Shimizu T., Kida Y., and Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6. J Immunol 175 (2005) 4641-4646
60. Thoma-Uszynski S., Kiertscher S.M., Ochoa M.T., Bouis D.A., Norgard M.V., Miyake K., et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165 (2000) 3804-3810
61. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62 (1998) 1315-1352
62. Finlay B.B., and Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 61 (1997) 136-169
63. Thanassi D.G., and Hultgren S.J. Multiple pathways allow protein secretion across the bacterial outer membrane. Curr Opin Cell Biol 12 (2000) 420-430
64. Meresse S., Steele-Mortimer O., Moreno E., Desjardins M., Finlay B., and Gorvel J.P. Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol 1 (1999) E183-E188
65. Hackstadt T. Redirection of host vesicle trafficking pathways by intracellular parasites. Traffic 1 (2000) 93-99
66. Huang X.Z., Nikolich M.P., and Lindler L.E. Current trends in plague research: from genomics to virulence. Clin Med Res 4 (2006) 189-199
67. 2)-activating protein (PLAA). Cell Signal 20 (2008) 844-861
68. Fadl A.A., Sha J., Klimpel G.R., Olano J.P., Niesel D.W., and Chopra A.K. Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar Typhimurium systemic infection. Infect Immun 73 (2005) 1081-1096